Difficulty in treating older hepatitis C patients with combination therapy
5th Jan 2006, 23:03 GMT
A new study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower long-term benefits in this age group.
Difficulty in treating older hepatitis C patients with combination therapy related news:
- Difficulty In Treating Older Hepatitis C Patients With Combination Therapy — Medical News Today RSS/XML Feed
- Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C — News-Medical News Feed
- Older Hepatitis C Patients Prove Difficult to Treat — RedOrbit News - Health
- Cyclosporine inhibits hepatitis C virus in vitro — EurekAlert! - Medicine and Health
- Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation — News-Medical News Feed
- Combination Better Than Monotherapy for Early Aggressive Arthritis — MedPage Today.com Latest Headlines
- REVIEW ARTICLE: Medical Progress: Autoimmune Hepatitis — New England Journal of Medicine -- Recent Issues
- Volume 42, number 3: Severe or Fatal Liver Injury in 50 Patients in the United States Taking Rifampbin and Pyrazinamide for Latent Tuberculosis Infection — Clin Infect Dis Latest Issue
- New Chemotherapy Regimen Improves Survival for Advanced Ovarian Cancer Patients — Blogcritics
- Cyclosporine Shows Advantage Over Tacrolimus — RedOrbit News - Health
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away